Ioannis Gounaris

3.7k total citations · 1 hit paper
47 papers, 1.3k citations indexed

About

Ioannis Gounaris is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ioannis Gounaris has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ioannis Gounaris's work include DNA Repair Mechanisms (5 papers), Cancer-related Molecular Pathways (5 papers) and Advanced Breast Cancer Therapies (5 papers). Ioannis Gounaris is often cited by papers focused on DNA Repair Mechanisms (5 papers), Cancer-related Molecular Pathways (5 papers) and Advanced Breast Cancer Therapies (5 papers). Ioannis Gounaris collaborates with scholars based in United Kingdom, United States and Germany. Ioannis Gounaris's co-authors include Gareth Hughes, Aditya Bardia, Nadia Harbeck, Marco Colleoni, Debu Tripathy, Helena Earl, Tetiana Taran, Arunava Chakravartty, Sara A. Hurvitz and Joohyuk Sohn and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLANT PHYSIOLOGY.

In The Last Decade

Ioannis Gounaris

45 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

2019 591 citations Ioannis Gounaris et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ioannis Gounaris United Kingdom	15	752	717	508	322	174	47	1.3k
Jacqui Rowbottom United Kingdom	10	791 1.1×	1.2k 1.7×	321 0.6×	567 1.8×	45 0.3×	14	1.6k
Lynda Grinsted United Kingdom	11	730 1.0×	850 1.2×	376 0.7×	703 2.2×	57 0.3×	19	1.4k
Miguel Martín Spain	8	657 0.9×	1.5k 2.1×	511 1.0×	753 2.3×	85 0.5×	15	1.9k
Eeva Kettunen Finland	19	441 0.6×	374 0.5×	440 0.9×	884 2.7×	50 0.3×	36	1.6k
A. W. Tolcher United States	19	310 0.4×	583 0.8×	201 0.4×	821 2.5×	72 0.4×	107	1.3k
Alexandr Poprach Czechia	21	632 0.8×	433 0.6×	848 1.7×	981 3.0×	75 0.4×	107	1.6k
Aglaya G. Iyevleva Russia	22	473 0.6×	588 0.8×	482 0.9×	689 2.1×	22 0.1×	78	1.5k
Habib Hamidi United States	16	335 0.4×	437 0.6×	310 0.6×	685 2.1×	39 0.2×	41	1.2k
Amelia Zelnak United States	15	388 0.5×	530 0.7×	310 0.6×	318 1.0×	146 0.8×	45	1.0k
Eliso Tikishvili United States	8	494 0.7×	310 0.4×	332 0.7×	434 1.3×	18 0.1×	14	915

Countries citing papers authored by Ioannis Gounaris

Since Specialization

Citations

This map shows the geographic impact of Ioannis Gounaris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioannis Gounaris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioannis Gounaris more than expected).

Fields of papers citing papers by Ioannis Gounaris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioannis Gounaris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioannis Gounaris. The network helps show where Ioannis Gounaris may publish in the future.

Co-authorship network of co-authors of Ioannis Gounaris

This figure shows the co-authorship network connecting the top 25 collaborators of Ioannis Gounaris. A scholar is included among the top collaborators of Ioannis Gounaris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioannis Gounaris. Ioannis Gounaris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yap, Timothy A., Elizabeth Ruth Plummer, Anthony W. Tolcher, et al.. (2024). A phase I study of highly potent oral ATR inhibitor (ATRi) tuvusertib plus oral PARP inhibitor (PARPi) niraparib in patients with solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 3018–3018. 2 indexed citations

Yap, Timothy A., Anthony W. Tolcher, Ruth Plummer, et al.. (2024). First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical Cancer Research. 30(10). 2057–2067. 20 indexed citations

Siu, Lillian L., Elena Garralda, Valentina Boni, et al.. (2024). Abstract CT063: Phase Ib trial of ATR inhibitor (ATRi) tuvusertib + ATM inhibitor (ATMi) lartesertib (M4076) in patients (pts) with advanced solid tumors. Cancer Research. 84(7_Supplement). CT063–CT063. 4 indexed citations

Burris, Howard A., Jordan Berlin, Hendrik‐Tobias Arkenau, et al.. (2024). A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours. British Journal of Cancer. 130(7). 1131–1140. 20 indexed citations

Wang, Danyi, Karthikeyan Murugesan, Kunal Shah, et al.. (2023). Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays. npj Precision Oncology. 7(1). 103–103. 11 indexed citations

Plummer, Ruth, Anthony W. Tolcher, Timothy A. Yap, et al.. (2023). Abstract CT272: Pharmacodynamic and immunophenotyping analyses of ATR inhibitor M1774 in a Phase I study in patients with solid tumors (DDRiver Solid Tumors 301). Cancer Research. 83(8_Supplement). CT272–CT272. 2 indexed citations

Mozgunov, Pavel, Thomas Jaki, Ioannis Gounaris, et al.. (2022). Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial. Statistics in Medicine. 41(30). 5789–5809. 5 indexed citations

Hicking, Christine, et al.. (2022). 457MO A phase I study of ATR inhibitor M1774 in patients with solid tumours (DDRiver Solid Tumours 301): Part A1 results. Annals of Oncology. 33. S747–S748. 14 indexed citations

Yap, Yoon Sim, Joanne Chiu, Yoshinori Ito, et al.. (2020). Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer. Cancer Science. 111(9). 3313–3326. 10 indexed citations

10.

Earl, Helena, Louise Hiller, Janet Dunn, et al.. (2017). Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial. Annals of Oncology. 28(8). 1817–1824. 28 indexed citations

11.

Gounaris, Ioannis, et al.. (2016). Lesson of the month 2: Cauda equina in Cushing’s syndrome. Clinical Medicine. 16(1). 88–90. 2 indexed citations

12.

Parkinson, Christine, Davina Gale, Anna Piskorz, et al.. (2016). Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study. PLoS Medicine. 13(12). e1002198–e1002198. 204 indexed citations

13.

Earl, Helena, Elena Provenzano, Jean Abraham, et al.. (2015). Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes – what does it all mean?. BMC Medicine. 13(1). 234–234. 44 indexed citations

14.

Wong, Han Hsi, Ioannis Gounaris, Ann McCormack, et al.. (2015). Presentation and management of pulmonary artery sarcoma. PubMed. 5(1). 3–3. 69 indexed citations

15.

Sayal, Karen, Ioannis Gounaris, Bristi Basu, et al.. (2015). Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 25(6). 977–984. 12 indexed citations

16.

Gounaris, Ioannis & James D. Brenton. (2014). Arid1A Role in Cell Cycle Regulation and Proliferation in Mouse and Human Gynaecological Tissues Reveals Potential Therapeutic Targets. Annals of Oncology. 25. iv53–iv53. 2 indexed citations

17.

Gounaris, Ioannis, et al.. (2007). Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinoma. Anti-Cancer Drugs. 18(10). 1227–1230. 6 indexed citations

18.

Sherwood, R. T., et al.. (1991). Inorganic salts modify embryo sac development in sexual and aposporous Cenchrus ciliaris. Sexual Plant Reproduction. 4(3). 22 indexed citations

19.

Wellburn, A. R., et al.. (1986). Development of bioenergetic function in light-grown seedlings. eCite Digital Repository (University of Tasmania). 6 indexed citations

20.

Gounaris, Ioannis, Christine B. Michalowski, Hans J. Bohnert, & Carl A. Price. (1986). Restriction and gene maps of plastid DNA from Capsicum annuum. Current Genetics. 11(1). 7–16. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact